Multidrug resistance among new tuberculosis cases: Detecting local variation through lot quality-assurance sampling

Epidemiology

Volumn 23, Issue 2, 2012, Pages 293-300

  Hedt, Bethany Lynn ^a   Van Leth, Frank ^b,c   Zignol, Matteo ^d   Cobelens, Frank ^b   Van Gemert, Wayne ^d   Nhung, Nguyen Viet ^e   Lyepshina, Svitlana ^f   Egwaga, Saidi ^g   Cohen, Ted ^h,i  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e National Lung Hospital   (Viet Nam)

^f DONETSK MEDICAL UNIVERSITY   (Ukraine)

^g National Tuberculosis Control Programme   (Tanzania)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLASSIFICATION; DRUG SENSITIVITY; HEALTH SURVEY; HUMAN; LOT QUALITY ASSURANCE SAMPLING; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; SAMPLE SIZE; SIMULATION; TANZANIA; UKRAINE; VIET NAM;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GEOGRAPHY; HUMANS; LOT QUALITY ASSURANCE SAMPLING; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TANZANIA; TUBERCULOSIS, PULMONARY; UKRAINE; VIETNAM;

EID: 84857039722     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3182459455     Document Type: Article

References (20)

1. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: World Health Organization; 2010. WHO/HTM/TB/2010.3.
2. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. Geneva: World Health Organization; 2009. WHO/HTM/TB/2009.422.
3. World Health Organization. Anti-tuberculosis drug resistance in the world. Geneva: World Health Organization; 2008. Report 4. WHO/ HTM/TB/2008.394.
4. Dodge HF, Romig HG. Sampling Inspection Tables. Single and Double Sampling. 2nd ed. New York: John Wiley; 1959.
5. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008;2(suppl):1-13. (Pubitemid 352019085)
6. Dubrovina I, Miskinis K, Lyepshina S, et al. Drug-resistant tuberculosis and HIV in Ukraine: A threatening convergence of two epidemics? Int J Tuberc Lung Dis. 2008;12:756-762. (Pubitemid 351976705)
7. Huong NT, Lan NT, Cobelens FG, et al. Antituberculosis drug resistance in the south of Vietnam: Prevalence and trends. J Infect Dis. 2006;194: 1226-1232. (Pubitemid 44630967)
8. Chonde TM, Doulla B, van Leth F, et al. Implementation of a national anti-tuberculosis drug resistance survey in Tanzania. BMC Public Health. 2008;8:427. doi:10.1186/1471-2458-8-427.
9. Myatt M, Bennett DE. A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings. Antivir Ther. 2008(suppl);2:37-48. (Pubitemid 352019088)
10. Myatt M, Limburg H, Minassian D, Katyola D. Field trial of applicability of lot quality assurance sampling survey method for rapid assessment of prevalence of active trachoma. Bull World Health Organ. 2003;81:877-885. (Pubitemid 38095337)
11. Myatt M, Mai HP, Quynh NQ, et al. Using lot quality-Assurance sampling and area sampling to identify priority areas for trachoma control: Viet Nam. Bull World Health Organ. 2005;83:756-763. (Pubitemid 41474694)
12. Deitchler M, Valadez JJ, Egge K, Fernandez S, Hennigan M. A field test of three LQAS designs to assess the prevalence of acute malnutrition. Int J Epidemiol. 2007;36:858-864. (Pubitemid 47394154)
13. Brooker S, Kabatereine NB, Myatt M, Stothard JR, Fenwick A. Rapid assessment of Schistosoma mansoni: The validity, applicability, and cost effectiveness of the Lot Quality Assurance Sampling method in Uganda. Trop Med Int Health. 2005;10:647-658. (Pubitemid 40933938)
14. Rabarijaona LP, Boisier P, Ravaoalimalala VE, et al. Lot quality assurance sampling for screening communities hyperendemic for Schistosoma mansoni. Trop Med Int Health. 2003;8:322-328. (Pubitemid 36513197)
15. Olives C, Pagano M. Bayes-LQAS: Classifying the prevalence of global acute malnutrition. Emerg Themes Epidemiol. 2010;7:3. doi:10.1186/ 1742-7622-7-3.
16. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005-1015.
17. World Health Organization. Rapid implementation of the Xpert MTB/ RIF diagnostic test: Technical and operational "How-to"; practical considerations. Geneva: World Health Organization; 2011. WHO/HTM/TB/ 2011.2.
18. Armitage S. Restricted sequential procedures. Biometrika. 1957;44: 9-26.
19. Hedt BL, Laufer M, Cohen T. Drug resistance surveillance in resourcepoor settings: Current methods and considerations for TB, HIV and malaria. Am J Trop Med Hyg. 2011;84:192-199.
20. Biedron C, Pagano M, Hedt BL, et al. An assessment of lot quality assurance sampling to evaluate malaria outcomes indicators: Extending malaria indicators surveys. Int J Epidemiol. 2010;39:72-79.